Compounds and compositions as TRK inhibitors
US8637516B2 · kind B2 · utility
59Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2011 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Sep 8, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.